SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001354488-08-000743
Filing Date
2008-05-01
Accepted
2008-04-30 20:16:08
Documents
12
Period of Report
2008-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 pharmanet8k.htm 8-K 11261
2 ex991.htm EX-99.1 133154
3 ex991001.jpg GRAPHIC 87327
4 ex991002.jpg GRAPHIC 87327
5 ex991003.jpg GRAPHIC 87327
6 exhibit992.htm EX-99.2 93251
7 exhibit992001.jpg GRAPHIC 87327
8 exhibit992002.jpg GRAPHIC 87327
9 exhibit992003.jpg GRAPHIC 87327
10 exhibit992004.jpg GRAPHIC 87327
11 exhibit992005.jpg GRAPHIC 87327
12 exhibit992006.jpg GRAPHIC 87327
  Complete submission text file 0001354488-08-000743.txt   1323330
Mailing Address 504 CARNEGIE CENTER PRINCETON NJ 08540-6242
Business Address 504 CARNEGIE CENTER PRINCETON NJ 08540-6242 609-951-6800
PharmaNet Development Group Inc (Filer) CIK: 0001089542 (see all company filings)

IRS No.: 592407464 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16119 | Film No.: 08791591
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9